Study identifier:D0980C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Phase I, First Time in Man, Single-Centre, Randomised, Double-Blind (within panels), Placebo-Controller Study to Investigate Safety, Tolerability and pharmacokinetics of AZD1704 after Administration of Oral Single Ascending Doses in Healthy Volunteers
Pain
Phase 1
Yes
AZD1704
All
80
Interventional
20 Years - 45 Years
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Other
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 | Drug: AZD1704 One dose, by mouth |